What to Expect When Starting Venlafaxine
Medical Disclaimer: This content is for informational purposes only and does not constitute medical advice. Always consult your healthcare provider before starting, stopping, or changing any medication. Using this site does not create a doctor-patient relationship.
Drug information changes as the FDA updates labeling, and we cannot guarantee it is complete or current. Verify critical details with your pharmacist or physician.
Emergencies: If you think you may have a medical emergency, call 911 immediately. For a suspected overdose, call Poison Control at 1-800-222-1222. Report side effects to the FDA MedWatch program at fda.gov/medwatch or 1-800-FDA-1088.
See our Terms of Use and Editorial Policy.
Introduction
Venlafaxine (brand name Effexor) is a serotonin-norepinephrine reuptake inhibitor (SNRI) prescribed for major depressive disorder, generalized anxiety disorder, social anxiety disorder, and panic disorder [1]. It works by inhibiting the reuptake of both serotonin and norepinephrine, increasing the availability of these neurotransmitters in the brain [2]. At lower doses (75 mg/day), venlafaxine primarily affects serotonin; at higher doses (150-225 mg/day), significant norepinephrine reuptake inhibition adds an additional therapeutic mechanism [2].
Venlafaxine is available in immediate-release (IR) tablets taken 2-3 times daily and extended-release (XR) capsules taken once daily [1]. The XR formulation is more commonly prescribed due to convenience and better tolerability. Like all antidepressants, venlafaxine takes several weeks to reach full therapeutic effect — this is a critical concept that many patients find challenging during the early adjustment period.
This guide covers what to expect when starting venlafaxine, including the timeline for therapeutic effects, common side effects during the adjustment period, and the importance of not stopping abruptly. Venlafaxine is particularly notable for its discontinuation syndrome — withdrawal symptoms can be more pronounced than with SSRIs, making gradual tapering essential when stopping [3]. Always follow your prescriber's specific instructions.
Week-by-week timeline
Starting the medication
Venlafaxine XR is typically started at 37.5-75 mg once daily [1]. Side effects often appear before therapeutic benefits — this is normal and expected with antidepressants. The most common early side effects include nausea (reported in 21-35% of patients), headache, dizziness, and insomnia or drowsiness [1][2]. These effects are usually most intense during the first few days as your brain adjusts to changing serotonin levels.
- Nausea, often most noticeable in the first 1-3 days
- Possible headache or dizziness
- Insomnia or drowsiness (varies by individual)
- Decreased appetite
- Dry mouth
- No improvement in depression or anxiety symptoms yet — this is expected
Adjustment period
During the first 1-2 weeks, your brain is adjusting to altered neurotransmitter levels [2]. Side effects are typically at their peak but beginning to stabilize. Some patients notice subtle improvements in anxiety, energy, or sleep quality before the full antidepressant effect emerges. Your provider may increase the dose after 1-2 weeks based on tolerability [1]. The FDA boxed warning notes that suicidal thoughts may increase in young adults (under 25) during the initial weeks of antidepressant treatment — close monitoring during this period is important [1].
- Side effects typically beginning to diminish
- Possible subtle improvement in anxiety or energy
- Possible increased sweating (one of venlafaxine's more persistent side effects)
- Sexual side effects may emerge (decreased libido, difficulty with orgasm)
- Sleep patterns adjusting — may improve or worsen temporarily
Therapeutic effects emerging
Meaningful improvement in depression and anxiety symptoms typically becomes apparent between weeks 3 and 6 [2]. Sleep quality, concentration, motivation, and emotional resilience often improve progressively during this period. Your provider may increase the dose to 150 mg or higher based on your response — the dose-response relationship for venlafaxine is well-established, with norepinephrine reuptake inhibition adding benefit at doses of 150 mg and above [2]. Side effects should be significantly reduced from the first week.
- Noticeable improvement in mood and anxiety
- Better sleep quality and concentration
- Initial side effects (nausea, dizziness) largely resolved
- Increased sweating may persist (affects ~10-14% of patients)
- Sexual side effects may persist
- Provider may adjust dose based on response
Full therapeutic effect and maintenance
The full therapeutic effect of venlafaxine is typically established by 8-12 weeks at the target dose [2]. At this point, your provider will assess the adequacy of your response and plan long-term maintenance. For major depression, guidelines recommend continuing treatment for at least 6-12 months after symptom remission to prevent relapse [4]. Long-term use is safe and effective — some patients benefit from years of continuous treatment. The most important long-term consideration is never stopping abruptly [3].
- Full antidepressant and anxiolytic effect established
- Stable mood and function improvement
- Long-term side effects (sweating, sexual effects) assessed and managed
- Provider planning maintenance duration
- Understanding the importance of gradual discontinuation if stopping
When to call your doctor
Contact your healthcare provider if you experience:
- New or worsening suicidal thoughts, self-harm urges, or extreme agitation — especially important in the first few weeks and for patients under 25 [1]
- Signs of serotonin syndrome if taking with other serotonergic medications: confusion, rapid heartbeat, high blood pressure, dilated pupils, muscle twitching, high fever [1]
- Severe or persistent nausea and vomiting that prevents adequate nutrition or hydration
- Significant increase in blood pressure — venlafaxine can raise blood pressure in a dose-dependent manner [1][2]
- Unusual bleeding or bruising (venlafaxine affects serotonin, which plays a role in platelet function) [1]
- Severe headache, confusion, or visual changes — rare hyponatremia (low sodium) can occur [1]
- Mania or hypomania: significantly decreased need for sleep, racing thoughts, excessive energy, impulsive behavior [1]
- Seizures (rare but reported) [1]
Tips for getting started
Take venlafaxine XR at the same time each day, preferably with food to reduce nausea [1]. Swallow extended-release capsules whole — do not crush, chew, or open them, as this destroys the extended-release mechanism and can cause a sudden release of the full dose. If you have difficulty swallowing capsules, the XR capsule can be opened and the contents sprinkled on applesauce and swallowed immediately without chewing [1].
Be patient during the first 2-4 weeks. Side effects often appear before therapeutic benefits, which can be discouraging. Understanding that this timeline is normal for antidepressants helps maintain adherence during the challenging early period. Keeping a brief daily mood journal can help you notice gradual improvements that are easy to miss day-to-day.
Never stop venlafaxine abruptly. Due to its short half-life (5 hours for the parent compound), venlafaxine produces more pronounced discontinuation symptoms than longer-acting antidepressants [3]. Common withdrawal symptoms include dizziness, nausea, headache, irritability, insomnia, and the characteristic "brain zaps" (brief electrical sensation-like feelings in the head). If you and your provider decide to discontinue, the dose should be tapered gradually over several weeks to months. Monitor your blood pressure periodically, as venlafaxine can increase blood pressure in approximately 3-13% of patients, particularly at higher doses [1].
Frequently asked questions
More about Venlafaxine
References
- [Regulatory] Venlafaxine (Effexor XR) FDA Prescribing Information. Pfizer. https://www.accessdata.fda.gov/drugsatfda_docs/label/2023/020151s066lbl.pdf Accessed 2026-03-01.
- [Regulatory] Venlafaxine. StatPearls [Internet]. National Library of Medicine. https://www.ncbi.nlm.nih.gov/books/NBK535363/ Accessed 2026-03-01.
- [Clinical] Fava GA, et al. Withdrawal Symptoms after SNRI and SSRI Discontinuation. Psychother Psychosom. 2018;87(4):195-203. https://pubmed.ncbi.nlm.nih.gov/30016772/ Accessed 2026-03-01.
- [Regulatory] APA Practice Guidelines for the Treatment of Major Depressive Disorder, 3rd Edition. American Psychiatric Association. https://psychiatryonline.org/doi/book/10.1176/appi.books.9780890426760 Accessed 2026-03-01.
Written and fact-checked by PrescriptionDrugs.org Editorial Team
Last updated: